The South Africa anti-infective market is expected to reach US$
2,572.5 Mn in 2027 from US$ 1,893.5 Mn in 2018. The market is estimated to grow with a CAGR of 3.6% from 2019-2027.
The growth of the market is driven by the factors such as,rise in the cases of viral diseases in South Africa. However, the market is likely to get impacted due to lack of awareness regarding fungal infections in South Africa.
In South Africa, almost 7.52 million people were living with HIV in 2018, as per data released by GHE. Also, during the year 2017, approximately 21% of South Africa patients living with HIV were from South Africa. The projected overall HIV prevalence rate during 2018 was almost 13.1% among the South African population, whereas for adults between 15-49 years, an estimated 19.0% of the population is found to be HIV positive. Also, South Africa has one of the highest rates of liver cancer in the world, which is related to the increased rate of HBV among adults.
Also, the incidences of tinea capitis are dominating in South Africa. Also, the country has a more significant number of tuberculosis and HIV, which further leads to a considerable amount of cases for chronic pulmonary aspergillosis (CPA). Moreover, as the data published at Gulf Conference on Clinical Microbiology and Infectious Diseases stated that approximately 99,350 cases of CPA were present in South Africa. The prevalence rate was nearly 175/100,000, which is the highest prevalence in the world. Furthermore, as per the data published by the CDC in April 2019 stated that in 2012-2016, Candida auris affected nearly 451 patients across the country. Therefore, owing to increasing prevalence across the country are likely to drive the growth of the anti-infective market during the forecast period.
South Africa anti-infective market, based on distribution channel was segmented into hospital pharmacies, retail pharmacies, and online pharmacies. In 2018, the hospital pharmacies segment held the largest share of the market, by distribution channel. This segment is also anticipated to grow at the highest rate during the forecast period.
Strategic insights for the South Africa Anti-Infective provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market. The geographic scope of the South Africa Anti-Infective refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas. South Africa Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
South Africa Anti-Infective Strategic Insights
South Africa Anti-Infective Report Scope
Report Attribute
Details
Market size in 2018
US$ 1,893.5 Million
Market Size by 2027
US$ 2,572.5 Million
Global CAGR (2019 - 2027)
3.6%
Historical Data
2016-2017
Forecast period
2019-2027
Segments Covered
By Type
By Range
By Distribution Channel
Regions and Countries Covered
South Africa
Market leaders and key company profiles
South Africa Anti-Infective Regional Insights
ASIA PACIFIC DIABETES CARE DEVICES – MARKET SEGMENTATION
By Type
By Application
By Distribution Channel
Company Profiles
The List of Companies
The South Africa Anti-Infective Market is valued at US$ 1,893.5 Million in 2018, it is projected to reach US$ 2,572.5 Million by 2027.
As per our report South Africa Anti-Infective Market, the market size is valued at US$ 1,893.5 Million in 2018, projecting it to reach US$ 2,572.5 Million by 2027. This translates to a CAGR of approximately 3.6% during the forecast period.
The South Africa Anti-Infective Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South Africa Anti-Infective Market report:
The South Africa Anti-Infective Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South Africa Anti-Infective Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South Africa Anti-Infective Market value chain can benefit from the information contained in a comprehensive market report.